Yahoo Finance Catalyst Biosciences, Inc. (NASDAQ:CBIO) insiders placed bullish bets worth US$941k in the last 12 months
In the last year, multiple insiders have substantially increased their holdings of Catalyst Biosciences, Inc. (NASDAQ:CBIO) stock, indicating that insiders' optimism about the company's prospects has increased.
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
View our latest analysis for Catalyst Biosciences
The Last 12 Months Of Insider Transactions At Catalyst Biosciences
In the last twelve months, the biggest single purchase by an insider was when insider Michael Torok bought US$936k worth of shares at a price of US$1.35 per share. That means that even when the share price was higher than US$0.21 (the recent price), an insider wanted to purchase shares. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. We note that Michael Torok was both the biggest buyer and the biggest seller.
Over the last year, we can see that insiders have bought 714.75k shares worth US$941k. But insiders sold 1.25m shares worth US$790k. Overall, Catalyst Biosciences insiders were net buyers during the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership Of Catalyst Biosciences
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Catalyst Biosciences insiders own about US$802k worth of shares (which is 10% of the company). Whilst better than nothing, we're not overly impressed by these holdings.
So What Do The Catalyst Biosciences Insider Transactions Indicate?
There haven't been any insider transactions in the last three months -- that doesn't mean much. However, our analysis of transactions over the last year is heartening. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Catalyst Biosciences stock. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Catalyst Biosciences. Our analysis shows 6 warning signs for Catalyst Biosciences (3 are concerning!) and we strongly recommend you look at them before investing.
Of course Catalyst Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
